在基于模型的剂量检测临床试验设计中包括共变体
Adrien Ollier1, Pavel Mozgunov1
1MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
在基于模型的I期剂量检测研究中纳入患者共变量可以提高安全性. 忽略预后共变量显著减少了正确的剂量选择,并增加了过量服用的风险.
科学领域:
- 临床药理学 临床药理学
- 生物统计学 生物统计学
- 药物开发 药物开发
背景情况:
- 基于模型的设计越来越多地用于I期剂量检测研究.
- 当前的方法往往假定患者有统一的毒性风险,忽视个体特征.
- 在临床试验中,患者的共同变量可以显著影响剂量-毒性关系.
研究的目的:
- 评估在基于模型的I期剂量确定中包含或省略患者共变量的影响.
- 评估对目标剂量建议和患者安全的影响.
- 建议改进统计模型,用于协变体的纳入.
主要方法:
- 研究了几种可变惩罚标准,用于共变量选择.
- 模拟的I期剂量检测场景与连续和二进制共变量.
- 提出并评估了贝叶斯逻辑回归模型 (BLRM),使用贝叶斯 LASSO 和 Spike-and-Slab priors.
主要成果:
- 忽略预后共变量导致正确选择的比例较低,并增加了过量服用.
- 包括共变量通常会改善操作特性,但可能会略微减少正确的选择.
- 使用贝叶斯 LASSO 和 Spike-and-Slab 的 BLRM 在处理变量包含方面表现出卓越的性能.
结论:
- 在I期试验中,患者共变量对于准确的剂量发现和安全至关重要.
- 当共变量对毒性产生影响时,标准方法可能是不理想的.
- 拟议的贝叶斯模型提供了一个可靠的方法,用于对共变量进行调整的剂量升级.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
20:24Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
Published on: January 31, 2014
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
